Insider Transaction Report for Eugene Durenard

Eugene Durenard, a director at Co-Diagnostics, Inc. (CODX), reported a transaction on May 23, 2026. Durenard acquired 1,695 shares of Common Stock, bringing his total holdings to 10,668 shares. Additionally, Durenard disposed of 1,695 units of Restricted Stock that were part of an award under the company's Long Term Incentive Plan. These units are set to vest in installments starting November 23, 2023, and November 23, 2024, and November 23, 2025. Following this transaction, Durenard holds 4,000 Restricted Stock Units. The transactions were reported on Form 4, filed on May 27, 2026.